Title
Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study
Date Issued
01 September 2021
Access level
open access
Resource Type
editorial
Author(s)
Publisher(s)
Lancet Publishing Group
Start page
e613
End page
e615
Volume
3
Issue
9
Language
English
OCDE Knowledge area
Enfermedades infecciosas
Scopus EID
2-s2.0-85113387314
Source
The Lancet Rheumatology
ISSN of the container
26659913
Sponsor(s)
RF has received consultancy fees from Pfizer and Janssen (unrelated to the VACOLUP study). MP has received consultancy fees from GSK and Pfizer (unrelated to the VACOLUP study). MFU-G reports grants from Janssen and Pfizer, and support for attending meetings and/or travel from Pfizer and Abbvie (unrelated to the VACOLUP study). LA has received consultancy fees from Pfizer and AstraZeneca (unrelated to the VACOLUP study). All other authors declare no competing interests. RF and LA verified all the data in the study. We wish to acknowledge the crucial role of the following patient associations: LupusEurope (@LupusEurope), Agrupación Lupus Chile (@Lupus_Chile), Lupus UK, Lupus France, AFL+, and Gruppo LES Italiano, in the dissemination of the survey. RF, LK, MD, and LA conceived the study. RF and LA curated the data. All authors did the investigation. RF, LK, MD, and LA devised the methodology. RF and LA wrote the original draft of the manuscript. All authors reviewed and edited the manuscript.
Sources of information:
Directorio de Producción Científica
Scopus